Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Earnings Preview: Merck & Co.
Yahoo/AP
Wednesday, July 25, 2012 - 9:25am
tags:
Merck, earnings
GlaxoSmithKline announces priority review for Promacta SNDA
The Fly on the Wall
Wednesday, July 25, 2012 - 9:24am
tags:
Promacta, GSK
Investing in the Companies that will Beat HIV
Motley Fool
Wednesday, July 25, 2012 - 9:22am
tags:
HIV, Gilead, JNJ, Merck, Bristol-Myers Squibb
Bristol-Myers Second-Quarter Profit Falls On Plavix Sales Drop
Bloomberg
Wednesday, July 25, 2012 - 9:08am
tags:
earnings, Bristol-Myers Squibb
Lilly Profit Beats Analyst Estimates As Cymbalta Sales Rise
Bloomberg
Wednesday, July 25, 2012 - 9:07am
tags:
earnings, Eli Lilly
10 Reasons Why Biotech Needs Big Data
Fierce Biotech IT
Tuesday, July 24, 2012 - 11:43pm
tags:
biotech, bioinformatics
Novavax pushes back additional testing of flu vaccine to 2013
Yahoo/AP
Tuesday, July 24, 2012 - 11:36pm
tags:
Flu, vaccines, Novavax
Impairment charge hits Illumina 2Q profit
Yahoo/AP
Tuesday, July 24, 2012 - 11:34pm
tags:
earnings, Illumina
Hopes dim for Alzheimer's trials after Pfizer failure
Reuters
Tuesday, July 24, 2012 - 11:32pm
tags:
Pfizer, Alzheimer's disease, Elan, JNJ, bapineuzumab
Questcor's Q2 Earnings Beat Expectations
Investors.com
Tuesday, July 24, 2012 - 11:30pm
tags:
earnings, Questcor
Yervoy Vs. Zelboraf: Melanoma Drugs Battle For Market Share
Seeking Alpha
Tuesday, July 24, 2012 - 11:21pm
tags:
Zelboraf, Yervoy, melanoma, GSK, Bristol-Myers Squibb, Roche
Roche’s Lucentis Works To Treat Vision Loss From Diabetes
Bloomberg
Tuesday, July 24, 2012 - 11:19am
tags:
Roche, diabetes, Lucentis, vision loss, diabetic macular edema
Sarepta jumps 113% to $7.37 after eteplirsen shows clinical benefit
Yahoo/Fly on the Wall
Tuesday, July 24, 2012 - 11:13am
tags:
eteplirsen, Sarepta
Biogen Second-Quarter Profit Rises As Avonex Sales Increase
Bloomberg
Tuesday, July 24, 2012 - 11:11am
tags:
earnings, BiogenIdec
Amarin, Horizon Pharma Build Momentum as Drug Approvals Near
Minyanville
Tuesday, July 24, 2012 - 10:12am
tags:
Amarin, AMR101, Horizon Pharma, FDA, rheumatoid arthritis, Lovaza
Forest targets rebounding growth as it fends off Icahn
Reuters
Tuesday, July 24, 2012 - 10:07am
tags:
Forest Labs, Carl Icahn
MAP Pharmaceuticals Reports Second Quarter of 2012 Financial Results
Yahoo
Tuesday, July 24, 2012 - 10:01am
tags:
earnings, MAP Pharmaceuticals
28 Drugs Facing FDA Approval in 2012-2013
TheStreet.com
Tuesday, July 24, 2012 - 9:52am
tags:
FDA, Amarin, Horizon Pharma, Salix, Progenics Pharmaceuticals, Regeneron, Sanofi, Talon Therapeutics, Gilead, Pfizer, Ironwood, Celgene, NPS Pharmaceuticals, Navidea Biopharmaceuticals
Medivation and Astellas Pharma's NDA for enzalutamide accepted by FDA
Yahoo/Fly on the Wall
Tuesday, July 24, 2012 - 9:41am
tags:
Enzalutamide, Medivation, Astellas, prostate cancer
On Efficacy, Vivus Vs. Arena
Seeking Alpha
Tuesday, July 24, 2012 - 9:26am
tags:
Vivus, Arena, obesity, Belviq, Qsymia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.